P-941 Phase II study of gefitinib (IRESSA) administered as...

Lung Cancer 2005 / 7 Vol. 49

P-941 Phase II study of gefitinib (IRESSA) administered as first linetreatment in patients with non-resectable, pneumonic-type adenocarcinoma (P-ADC)

Cadranel, J., Debove, P., Quoix, E., Soria, J., Friard, S., Perol, M., Souquet, P., Vergnenegre, A., Morot-Sibilot, D., Milleron, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81434-5
Date:
July, 2005
File:
PDF, 152 KB
english, 2005
Conversion to is in progress
Conversion to is failed